全文获取类型
收费全文 | 476065篇 |
免费 | 61522篇 |
国内免费 | 23280篇 |
专业分类
耳鼻咽喉 | 7946篇 |
儿科学 | 9252篇 |
妇产科学 | 7998篇 |
基础医学 | 40792篇 |
口腔科学 | 7509篇 |
临床医学 | 70632篇 |
内科学 | 95723篇 |
皮肤病学 | 10884篇 |
神经病学 | 32042篇 |
特种医学 | 18069篇 |
外国民族医学 | 170篇 |
外科学 | 72854篇 |
综合类 | 53135篇 |
现状与发展 | 141篇 |
一般理论 | 36篇 |
预防医学 | 28110篇 |
眼科学 | 12803篇 |
药学 | 35501篇 |
297篇 | |
中国医学 | 18268篇 |
肿瘤学 | 38705篇 |
出版年
2024年 | 1310篇 |
2023年 | 8781篇 |
2022年 | 13183篇 |
2021年 | 18702篇 |
2020年 | 17518篇 |
2019年 | 12515篇 |
2018年 | 18319篇 |
2017年 | 17247篇 |
2016年 | 17411篇 |
2015年 | 22690篇 |
2014年 | 33235篇 |
2013年 | 31925篇 |
2012年 | 30018篇 |
2011年 | 32709篇 |
2010年 | 27226篇 |
2009年 | 27601篇 |
2008年 | 23660篇 |
2007年 | 21936篇 |
2006年 | 24140篇 |
2005年 | 20931篇 |
2004年 | 14290篇 |
2003年 | 12483篇 |
2002年 | 10815篇 |
2001年 | 11520篇 |
2000年 | 10917篇 |
1999年 | 11244篇 |
1998年 | 8275篇 |
1997年 | 7995篇 |
1996年 | 7043篇 |
1995年 | 6626篇 |
1994年 | 4851篇 |
1993年 | 3386篇 |
1992年 | 4069篇 |
1991年 | 3737篇 |
1990年 | 2956篇 |
1989年 | 2780篇 |
1988年 | 2510篇 |
1987年 | 2105篇 |
1986年 | 1923篇 |
1985年 | 1505篇 |
1984年 | 1053篇 |
1983年 | 919篇 |
1982年 | 749篇 |
1981年 | 629篇 |
1980年 | 530篇 |
1979年 | 586篇 |
1978年 | 484篇 |
1977年 | 532篇 |
1975年 | 382篇 |
1972年 | 430篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
目的:观察非霍奇金淋巴瘤(non-Hodgkin's lymphoma,NHL)患者自体造血干细胞移植(autologous hematopoietic stem cell transplantation,ASCT)术后应用重组人α-2b干扰素(α-2b IFN)进行早期干预治疗的临床疗效。方法:选取18例行ASCT的NHL患者为研究对象,移植前疾病评估均未达到完全缓解(complete remission,CR),试验组血象恢复后给予IFN 3 000 000 U次/隔日干预治疗,3个月后停用;对照组未行干扰素干预治疗,分析总体疗效及两组对比的生存情况。结果:随访中位时间为34(10~50)个月,患者中位生存时间为37(31~45)个月,3年总体无进展生存(progressive free survival,PFS)、总生存(overall survivial,OS)分别为54.7%、66.8%。ASCT后试验组1年内无疾病复发,2年内复发率为12.5%;对照组1年内复发率为20%,2年内复发率为30%。结论:NHL患者在ASCT后给予重组人α-2b IFN早期干预治疗,患者耐受性好,可能降低移植后早期复发率。 相似文献
43.
44.
45.
Autoimmune comorbid diseases associated with lichen planus: a nationwide case–control study 下载免费PDF全文
46.
47.
Interprofessional collaboration and communication in nursing homes: a qualitative exploration of problems in medical care for nursing home residents – study protocol 下载免费PDF全文
48.
Yang Liu Yanyan Gao Hengliang Liu Qi Chen Jinrui Ji Kailong Jia 《Arquivos brasileiros de cardiologia》2021,116(2):229
BackgroundDual antiplatelet therapy (DAPT) is the cornerstone treatment of acute myocardial infarction (AMI).ObjectiveThe present study aimed to investigate the efficacy and safety of triple antiplatelet therapy (TAPT) in elderly female patients with diabetes and ST segment elevation myocardial infarction (STEMI), who had undergone percutaneous coronary intervention (PCI).MethodsWe designed a randomized, single-blind study. Control group A (97 elderly male patients with diabetes and STEMI, whose CRUSADE scores were < 30) received aspirin, ticagrelor, and tirofiban. A total of 162 elderly female patients with diabetes and STEMI were randomly divided into two groups according to CRUSADE score. Group B (69 patients with CRUSADE score > 31) received aspirin and ticagrelor. Group C (93 patients with CRUSADE score < 30) received aspirin, ticagrelor and tirofiban. P values < 0.05 were considered statistically significant.ResultsCompared to the findings in group A, post-PCI Thrombolysis in Myocardial Infarction (TIMI) grade 3 blood flow and TIMI myocardial perfusion grade 3 were significantly less prevalent in group B (p < 0.05). When compared to groups A and C, the incidence of major adverse complications was significantly higher in group B (p < 0.05).ConclusionTAPT could effectively reduce the incidence of major complications in elderly female patients with diabetes and STEMI. However, close attention should be paid to hemorrhage in patients receiving TAPT. (Arq Bras Cardiol. 2020; [online].ahead print, PP.0-0) 相似文献
49.
50.
Shasha Yuan Fang Wang Yan Zhao Yun Liu 《The International journal of health planning and management》2020,35(1):e196-e209
Since the new round of health care reform in 2009, the vertical integration of hospitals and primary health institutions has become widely implemented in China as an efficient method for improving quality of primary care. This study aimed to answer the following questions: (a) What is the perceived quality of township health centres (THCs) under integration? (B) What differences could be observed among the three typical integration models, namely, private hospital-THC integration, public hospital-THC integration, and loose collaboration? Two rounds of cross-sectional surveys were conducted from November 2016 to June 2018. The Chinese version of the Primary Care Assessment Tool was used to evaluate perceived quality of sample THCs, and 1118 adult patients were interviewed in total. Multiple linear regressions were employed to compare the quality scores between two survey rounds and among different integration models after controlling for potential confounders. The results revealed that the quality of care significantly improved under private hospital-THC integration as observed by comparing two survey rounds, while no change or slight changes were observed in the other two models. The difference observed among the three models was that the perceived quality of THCs integrated with private hospitals was worse than that of THCs integrated with public hospitals and THCs under loose collaboration, while no significant difference was observed between public hospital-THC integration and loose collaboration. Increased attention should be given to highlighting the tight integration between hospitals and THCs and the different roles played by private and public hospitals in the current reform. 相似文献